Previous 10 | Next 10 |
2023-03-16 13:34:02 ET VolitionRx Limited (VNRX) Q4 2022 Earnings Conference Call March 16, 2023 8:30 AM ET Company Participants Scott Powell – Executive Vice President-Investor Relations Cameron Reynolds – President and Group Chief Executive Officer ...
2023-03-16 10:48:22 ET The following slide deck was published by VolitionRx Limited in conjunction with their 2022 Q4 earnings call. For further details see: VolitionRx Limited 2022 Q4 - Results - Earnings Call Presentation
2023-03-16 09:10:41 ET Esperion Therapeutics ESPR -58% in dustup with Daiichi Sankyo over milestone payments . LivePerson LPSN -38% on Q4 earnings release . Virgin Orbit VORB -37% on reports it's pausing operations as it seeks funding . First Republ...
VolitionRx Limited Announces Full Fiscal Year 2022 Financial Results and Business Update PR Newswire Conference call to discuss financial and operational results scheduled for Thursday, March 16 , at 8:30 a.m. U.S. Eastern Time Executed global licensing and...
NEW YORK, March 10, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Sciences Virtual Investor Forum held on March 9th are now available for online viewing. REGISTER NOW AT : ...
VolitionRx Limited Schedules Full Year 2022 Earnings Conference Call and Business Update PR Newswire Conference call to take place on Thursday March 16 at 08:30 a.m. Eastern Time HENDERSON, Nev. , March 10, 2023 /PRNewswire/ -- VolitionRx Limited ...
NEW YORK, March 07, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Life Sciences Virtual Investor Forum to be held March 9 th . Individual investors, institutional investors, advisors, and analysts ...
HENDERSON, Nev., March 06, 2023 (GLOBE NEWSWIRE) -- VolitionRx Limited (NYSE AMERICAN: VNRX), a multi-national epigenetics company, today announced that Scott Powell, Vice President of Investor Relations at VolitionRx Limited and Chief Investment Officer of Volition America, will present liv...
VolitionRx Limited Announces Closing of $8.7 Million Underwritten Public Offering of Common Stock PR Newswire HENDERSON, Nevada , Feb. 22, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announced ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock Investors are wondering if the stock market is open on Presidents’ Day 2023 as they make weekend plans. The quick and simple answer investors are looking for is no, the stock market will not...
News, Short Squeeze, Breakout and More Instantly...
VolitionRx Limited (NYSE American: VNRX) , a multi-national epigenetics company focused on saving lives and improving outcomes for people and animals with life-altering diseases, announced the engagement of PharmaVentures Ltd (“PharmaVentures”) to act as an advisor. PharmaVentures w...
Volition appoints PharmaVentures for Capture PCR™ and oncology portfolio licensing PR Newswire HENDERSON, Nev. , July 9, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has appointed PharmaV...
VolitionRx Limited (NYSE American: VNRX) (“Volition”), a multi-national epigenetics company focused on saving lives and improving outcomes for people and animals with life-altering diseases, has released a mid-year review that highlights significant milestones, such as the expansio...